Suven Life Sciences' histamine H3 receptor antagonist improves cognitive performance in vivo April 13, 2011
IND application filed for mTOR/PI3K-alpha inhibitor PWT-33597 based on in vivo antitumor action April 13, 2011
High-dose once-weekly rosuvastatin shows comparable safety/efficacy to standard daily atorvastatin April 12, 2011
New PET tracer BAY-94-9392 distinguishes tumors from inflammation in vivo; phase I trials ongoing April 12, 2011
RSS